Measuring performance status in pediatric patients with brain tumors—experience of the HIT‐GBM‐C protocol

  title={Measuring performance status in pediatric patients with brain tumors—experience of the HIT‐GBM‐C protocol},
  author={J. Wolff and K. Mohiuddin and N. Jorch and N. Graf and Sabine Wagner and T. Vats and A. Gnekow},
  journal={Pediatric Blood & Cancer},
  • J. Wolff, K. Mohiuddin, +4 authors A. Gnekow
  • Published 2010
  • Medicine
  • Pediatric Blood & Cancer
  • Measuring the quality of life or performance status in pediatric neurooncology has proven a challenge. Here, we report in a treatment protocol for pediatric patients with high‐grade glioma and diffuse intrinsic pontine glioma. 
    2 Citations
    Pediatric high grade glioma of the spinal cord: results of the HIT-GBM database
    • 26
    Musashi1 enhances chemotherapy resistance of pediatric glioblastoma cells in vitro
    • 2


    The prognostic value of cognitive functioning in the survival of patients with high-grade glioma
    • 83
    • Highly Influential
    Subpopulations of malignant gliomas in pediatric patients: analysis of the HIT-GBM database
    • 46
    Cognitive function as a predictor of survival in patients with recurrent malignant glioma.
    • 220
    • Highly Influential
    Treatment options in childhood pontine gliomas
    • 67
    Valproic acid was well tolerated in heavily pretreated pediatric patients with high-grade glioma
    • 44
    • PDF
    Neurocognitive deficits in medulloblastoma survivors and white matter loss
    • 203
    Quality of life in patients with brain tumor: what's relevant in our quest for therapeutic efficacy.
    • 13
    • Highly Influential
    • PDF
    Quantifying health status outcomes in pediatric medulloblastoma patients.
    • 11
    Treatment of paediatric pontine glioma with oral trophosphamide and etoposide
    • 61